Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients
暂无分享,去创建一个
J. Sánchez-Céspedes | E. Cordero | J. Pachón | J. Rodríguez-Baño | J. Cisneros | C. Infante | R. Álvarez-Marín | J. Oteo | Z. Palacios-Baena | C. Roca | P. Pérez-Palacios | G. Bernal | J. M. Sobrino | Sonsoles Salto-Alejandre | E. García-Díaz | Judith Berastegui-Cabrera | P. Camacho-Martínez | Josune Goikoetxea-Aguirre | S. Santibáñez | J. Alba | R. Rodríguez-Álvarez | Javier Nieto-Arana | Concepción García-García | Natalia Maldonado | J. A. Lepe | Á. Pascual | J. Praena | M. J. Blanco-Vidal | David Gutiérrez-Campos | M. Gómez‐Bravo | M. Aguilar-Guisado | Marta Carretero-Ledesma | Rocío Valverde-Ortiz | María José Blanco-Vida | Zaira R Palacios-Baena
[1] Ganlin Zhang,et al. Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: A systematic review and meta-analysis of 16 cohort studies , 2022, Journal of Infection.
[2] Yasser Fakri Mustafa,et al. The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update , 2022, Journal of medical virology.
[3] P. Gregersen,et al. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Edmond,et al. Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis , 2022, Journal of Infection.
[5] E. Coccia,et al. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection , 2021, bioRxiv.
[6] J. Richards,et al. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality , 2021, medRxiv.
[7] J. Casanova,et al. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4 , 2021, The Journal of experimental medicine.
[8] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[9] J. Greenbaum,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.
[10] R. Trimble. COVID-19 Dashboard , 2020 .